{"pmid":32486842,"title":"Battlefield Endocrinology.","text":["Battlefield Endocrinology.","J Diabetes Sci Technol","Sadhu, Archana R","32486842"],"journal":"J Diabetes Sci Technol","authors":["Sadhu, Archana R"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32486842","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1177/1932296820930275","keywords":["covid-19","blood glucose","continuous glucose monitor","critically ill","diabetes mellitus","insulin infusion","intensive care unit (icu)"],"topics":["Prevention"],"weight":1,"_version_":1668623433757360128,"score":9.490897,"similar":[{"pmid":32279224,"pmcid":"PMC7150529","title":"COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology.","text":["COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology.","Endocrine","Puig-Domingo, M","Marazuela, M","Giustina, A","32279224"],"journal":"Endocrine","authors":["Puig-Domingo, M","Marazuela, M","Giustina, A"],"date":"2020-04-13T11:00:00Z","year":2020,"_id":"32279224","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1007/s12020-020-02294-5","keywords":["covid-19","diabetes mellitus","hypoadrenalism","malnourishment","obesity"],"link_comment_in":"32253680","topics":["Diagnosis","Prevention"],"weight":1,"_version_":1666138491575074816,"score":69.984314},{"pmid":32450726,"title":"The COVID-19 Pandemic: A \"Tech\"-tonic Shift Toward Virtual Diabetes Care.","text":["The COVID-19 Pandemic: A \"Tech\"-tonic Shift Toward Virtual Diabetes Care.","J Diabetes Sci Technol","Ahn, David T","32450726"],"journal":"J Diabetes Sci Technol","authors":["Ahn, David T"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32450726","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1177/1932296820929719","keywords":["covid-19","continuous glucose monitor","coronavirus","population health","telehealth","telemedicine","virtual visit"],"topics":["Prevention"],"weight":1,"_version_":1667983494566903808,"score":66.99229},{"pmid":32336959,"pmcid":"PMC7171388","title":"SARS-CoV-2 (COVID-19) and intravascular volume management strategies in the critically ill.","text":["SARS-CoV-2 (COVID-19) and intravascular volume management strategies in the critically ill.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread across the globe, and millions of people may be affected. While knowledge regarding epidemiologic features and diagnostic tools of coronavirus disease 2019 (COVID-19) is rapidly evolving, uncertainties surrounding various aspects of its optimal management strategies persist. A subset of these patients develop a more severe form of the disease characterized by expanding pulmonary lesions, sepsis, acute respiratory distress syndrome, and respiratory failure. Due to lack of data on treatment strategies specific to this subset of patients, currently available evidence on management of the critically ill needs to be extrapolated and customized to their clinical needs. The article calls attention to fluid stewardship in the critically ill with COVID-19 by judiciously applying the evidence-based resuscitation principles to their specific clinical features such as high rates of cardiac injury. As we await more data from treating these patients, this strategy is likely to help reduce potential complications.","Proc (Bayl Univ Med Cent)","Kazory, Amir","Ronco, Claudio","McCullough, Peter A","32336959"],"abstract":["The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread across the globe, and millions of people may be affected. While knowledge regarding epidemiologic features and diagnostic tools of coronavirus disease 2019 (COVID-19) is rapidly evolving, uncertainties surrounding various aspects of its optimal management strategies persist. A subset of these patients develop a more severe form of the disease characterized by expanding pulmonary lesions, sepsis, acute respiratory distress syndrome, and respiratory failure. Due to lack of data on treatment strategies specific to this subset of patients, currently available evidence on management of the critically ill needs to be extrapolated and customized to their clinical needs. The article calls attention to fluid stewardship in the critically ill with COVID-19 by judiciously applying the evidence-based resuscitation principles to their specific clinical features such as high rates of cardiac injury. As we await more data from treating these patients, this strategy is likely to help reduce potential complications."],"journal":"Proc (Bayl Univ Med Cent)","authors":["Kazory, Amir","Ronco, Claudio","McCullough, Peter A"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32336959","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1080/08998280.2020.1754700","keywords":["covid-19","congestion","sars-cov-2","critically ill","resuscitation"],"locations":["optimal"],"topics":["Treatment"],"weight":1,"_version_":1666138494179737601,"score":59.679405},{"pmid":32460551,"title":"The Time of Uncertainty in Poland.","text":["The Time of Uncertainty in Poland.","J Diabetes Sci Technol","Dzida, Grzegorz J","32460551"],"journal":"J Diabetes Sci Technol","authors":["Dzida, Grzegorz J"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32460551","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1177/1932296820931485","keywords":["covid-19","blood glucose","diabetes","infection","morbidity"],"locations":["Poland"],"countries":["Poland"],"countries_codes":["POL|Poland"],"weight":0,"_version_":1668079521554759680,"score":59.679405},{"pmid":32470146,"title":"Elevated interleukin-6 is associated with severity of COVID-19: a meta-analysis.","text":["Elevated interleukin-6 is associated with severity of COVID-19: a meta-analysis.","Coronavirus disease 2019 (COVID-19) has spread rapidly around the world since its emergence in humans last December. Previous studies suggested that numerous markers of inflammation were elevated in patients in with severe disease relative to patients with milder conditions, and an elevated level of interleukin-6 (IL-6) was associated with a high case fatality of COVID-19 infection. This article is protected by copyright. All rights reserved.","J Med Virol","Zhu, Jieyun","Pang, Jielong","Ji, Pan","Zhong, Zhimei","Li, Hongyuan","Li, Bocheng","Zhang, Jianfeng","32470146"],"abstract":["Coronavirus disease 2019 (COVID-19) has spread rapidly around the world since its emergence in humans last December. Previous studies suggested that numerous markers of inflammation were elevated in patients in with severe disease relative to patients with milder conditions, and an elevated level of interleukin-6 (IL-6) was associated with a high case fatality of COVID-19 infection. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Zhu, Jieyun","Pang, Jielong","Ji, Pan","Zhong, Zhimei","Li, Hongyuan","Li, Bocheng","Zhang, Jianfeng"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32470146","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/jmv.26085","keywords":["2019 coronavirus disease","interleukin-6","meta-analysis","severe disease","critically ill"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1668420887313907712,"score":58.962513}]}